Cataract Surgery and your Intraocular Lens (IOL) Choices

WHAT ARE CATARACTS?Cataracts are a clouding of the natural lens in your eye, which makes vision blurry.1

EYE WITH CATARACTEYE WITHOUT CATARACT

CataractLens

Cornea

Retina * simulated vision, individual symptoms may vary

CATARACT REMOVAL LENS INSERTION VISION RESTORED

Recovery after cataract surgery usually occurs within a few days.2 See the chart of options below

Cataract

Incision

Your Intraocular Lens (IOL) Choices

AstigmatismDistanceIntermediateNear

Monofocal Lens • Designed to provide clear distance vision• You will likely still need glasses for reading (and possibly distance vision)3

Astigmatism-Correcting Monofocal Lens• Corrects both cataracts and astigmatism• Designed to provide clear distance vision without glasses• You will likely still need glasses for reading4

Next-Generation Trifocal Lens• Corrects cataracts• Designed to provide a full range of vision–near, far and in-between5

• Not designed to correct for astigmatism

Next-Generation Trifocal Toric Lens• Corrects cataracts and astigmatism• Designed to provide a full range of vision–near, far and in-between6

Intraocular Lens Choices

Visit www.seethefullpicture.ca for more information

Cataract Surgery

Intraocular Lens Choices

ASTIGMATISM-CORRECTING IOLS71% of cataract patients have corneal astigmatism, which is a common condition that may produce blurry vision.

What you may see without glasses after you correct your cataracts

What you may see without glasses after you correct your

cataracts and astigmatism together

The simulated images above are for illustration purposes only.

TRIFOCAL IOLSTrifocal IOLs are designed to provide clear vision without glasses after cataract surgery

at near, intermediate and far distances.

The simulated images above are for illustration purposes only.

Clear vision without glasses may be possible after cataract surgery© 2018 Novartis 03/18 GL-MCAT-18-CANE-0321a

AcrySof® IQ IOL CAUTION: Federal law restricts this device to sale by or on the order of a physician. WARNINGS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. PRECAUTIONS: Do not resterilize. Do not store over 45° C. Use only sterile irrigating solutions such as BSS® or BSS® PLUS Sterile Intraocular Irrigating Solution. Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. In a previous study, posterior capsule opacification (PCO), when present, was recognized earlier as clinically significant PCO with the AcrySof® ReSTOR® lenses as compared to the monofocal control. ATTENTION: Reference the Physician labeling/Directions for Use for a complete list of indications, warnings and precautions. The long-term effects of filtering blue light and the clinical efficacy of that filtering on the retina have not been conclusively established.AcrySof®  IQ Toric IOL CAUTION: Federal law restricts this device to sale by or on the order of a physician. INDICATIONS: AcrySof®  IQ Toric Intraocular lenses are intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia and pre-existing corneal astigmatism secondary to the removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision. WARNINGS: You, as the patient, should consult your eye care provider for full disclosure of risk and benefits of cataract surgery and lens choices. PRECAUTIONS: As with any surgical procedure, there are risks involved including visual disturbances and secondary surgical intervention. The effect on vision of the AcrySof®  Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied.AcrySof® IQ PanOptix® Presbyopia Correcting Intraocular Lenses Important Product Information INDICATIONS: The AcrySof® IQ PanOptix® Presbyopia Correcting Intraocular Lens is intended for primary implantation in the capsular bag in the posterior chamber for the visual correction of aphakia secondary to removal of a cataractous lens in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence. WARNINGS: As with any surgical procedure, there are associated risks. Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens of this type. This is particularly so in a patient with any of the conditions described in the AcrySof® IQ PanOptix® physician labeling. Some patients may experience visual disturbances and/or difficulty seeing due to the multifocal lens design, especially under dim light conditions. As with other multifocal IOLs, visual symptoms may be significant enough that the patient will request explantation of an AcrySof ® IQ PanOptix ® IOL. Posterior capsule opacification (PCO) may significantly affect the vision of patients with multifocal IOLs sooner in its progression than in patients with monofocal IOLs. ATTENTION: Refer to the Directions for Use labeling for Model TFNT00 for a complete listing of indications, warnings and precautions. AcrySof® IQ PanOptix® Toric Presbyopia Correcting Intraocular Lenses The AcrySof* IQ PanOptix* Toric Presbyopia Correcting intraocular lens is intended for primary implantation in the capsular bag in the posterior chamber of the human eye for the visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence. As with any surgical procedure, there are associated risks. Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens of this type. This is particularly so in a patient with any of the conditions described in the AcrySof IQ PanOptix Toric IOL physician labeling. The AcrySof IQ PanOptix Toric IOL corrects corneal astigmatism only when it is placed in the correct position in the eye. There is a possibility that the IOL could be placed incorrectly or could move within the eye. This may result in less improvement or a reduction in vision because the corneal astigmatism has not been fully corrected, or it may cause visual symptoms. Some patients may experience visual disturbances and/or difficulty seeing due to the multifocal lens design, especially under dim light conditions. As with other multifocal IOLs, visual symptoms may be significant enough that the patient will request explanation of an AcrySof IQ PanOptix Toric IOL. Posterior capsule opacification (PCO) may significantly affect the vision of patients with multifocal IOLs sooner in its progression than in patients with monofocal IOLs.References: 1. National Eye Institute Staff. Facts About Cataract. National Eye Institute. September 2009. https://nei.nih.gov/health/cataract/cataract_facts. 2. Mayo Clinic Staff. What you can expect [Cataract Surgery]. Mayo Clinic. July 30, 2013. http://www.mayoclinic.org/tests- procedures/cataract-surgery/details/what- youcan-expect/rec- 20229550. Accessed January 27, 2016. 3. AcrySof IQ IOL Directions For Use. Alcon Canada Inc. 4. AcrySof IQ Toric IOL Directions For Use. Alcon Canada Inc. 5. AcrySof IQ PanOptix IOL Directions For Use. Alcon Canada Inc. 6. AcrySof IQ PanOptix Toric IOL Directions For Use. Alcon Canada Inc.